Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Listeria monocytogenes-associated respiratory infections: a study of 38 consecutive cases

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Contributors:
      Service des Maladies infectieuses et tropicales CHU Necker; Hôpital Necker - Enfants Malades AP-HP; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP); Centre National de Référence Listeria - National Reference Center Listeria (CNRL); Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM); Centre collaborateur de l'OMS Listeria / WHO Collaborating Centre Listeria (CC-OMS / WHO-CC); Institut Pasteur Paris (IP)-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO); Biologie des Infections - Biology of Infection; Université Paris Descartes - Paris 5 (UPD5); Funding was received from the Institut Pasteur, Santé Publique, France.
    • Publication Information:
      HAL CCSD
      Elsevier for the European Society of Clinical Microbiology and Infectious Diseases
    • Publication Date:
      2018
    • Collection:
      Institut Pasteur: HAL
    • Abstract:
      International audience ; Objectives: Listeria monocytogenes (Lm) is a foodborne human pathogen responsible for severe infections, including septicaemia, neurolisteriosis, and maternalefoetal and focal infections. Little is known about Lm-associated respiratory tract or lung infections. Methods: We conducted a retrospective study of culture-proven cases of Lm pleural infections and pneumonia Results: Thirty-eight consecutive patients with pleural infection (n ¼ 32), pneumonia (n ¼ 5), or both (n ¼ 1) were studied; 71% of these were men. Median age was 72 (range 29e90). Two patients presented with concomitant neurolisteriosis. All patients but one reported at least one immunosuppressive condition (97%), with a median number of 2 (range 0e5), including 29% (8/28) with current exposure to immunosuppressive therapy and 50% (17/34) with ongoing neoplasia; 75% (21/28) reported previous pleural or pulmonary disease. Antibiotic therapy mostly consisted in amoxicillin (72%) associated with aminoglycoside in 32%. Chest-tube drainage was performed in 7/19 patients with empyema (37%); 25% of the patients (7/30) required intensive care management. In-hospital mortality reached 35% and occurred after a median time interval of 4 days (range 1e33 days). Three patients had recurrence of empyema (time interval of 1 week to 4 months after treatment completion). Altogether, only 13/31 patients (42%) diagnosed with Lm respiratory infection experienced an uneventful outcome at 2-year follow-up. Conclusion: Lm is a rare but severe cause of pneumonia and pleural infection in older immunocom-promised patients, requiring prompt diagnosis and adequate management and follow-up.
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/29549058; pasteur-02449011; https://pasteur.hal.science/pasteur-02449011; https://pasteur.hal.science/pasteur-02449011/document; https://pasteur.hal.science/pasteur-02449011/file/Morgand%20Ms%20R1%20unmarked.pdf; PUBMED: 29549058
    • Accession Number:
      10.1016/j.cmi.2018.03.003
    • Online Access:
      https://doi.org/10.1016/j.cmi.2018.03.003
      https://pasteur.hal.science/pasteur-02449011
      https://pasteur.hal.science/pasteur-02449011/document
      https://pasteur.hal.science/pasteur-02449011/file/Morgand%20Ms%20R1%20unmarked.pdf
    • Rights:
      http://creativecommons.org/licenses/by-nc/ ; info:eu-repo/semantics/OpenAccess
    • Accession Number:
      edsbas.C0AF771D